Healthcare Triangle, Inc. to Announce Q3 2026 Financial Results
Healthcare Triangle, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 5, 2026.
Stocks · News reference
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report came out
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Healthcare Triangle, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 5, 2026.
NewcelX Ltd. has agreed to divest its worldwide Mazindol asset portfolio to REA Holdings Inc. in a deal involving upfront cash, equity, and potential milestone payments.
Innate Pharma S.A. released its financial results for the nine months ended September 30, 2026, highlighting a strengthened cash position and progress in its clinical pipeline.
Valneva SE has announced that it will release its consolidated financial results for the first nine months of 2026 on November 24, 2026.
Cibus, Inc. has scheduled its third quarter 2026 financial results announcement and conference call for November 12, 2026.
Zentalis Pharmaceuticals announced that its management team will participate in two investor conferences in November 2026.